Skip to content
Use caution Drug recall · FDA · Published February 26, 2014

Advil PM Caplets Recall: Subpotent Diphenhydramine

Pfizer recalls Advil PM Caplets due to subpotent diphenhydramine levels. Check your bottle NDC and lot number for details on this Class III recall.

🇺🇸 FDA recall #D-1166-2014DrugAdvil ›
Take action

Contact the company

Recalling firmPfizer Us Pharmaceutical Group235 E 42nd St · New York, NY 10017-5703
✎ GovInfoNow plain-language explainer

Pfizer is recalling a specific lot of Advil PM Caplets because testing showed the diphenhydramine content was lower than specified. This means the medication may not work as intended to help with sleep or pain relief. The recall affects 70,704 bottles distributed nationwide. Read more at govinfonow.com/recall/46239-pfizer-us-pharmaceutical-group-recalls-advil-pm-caplets-ibuprofen-200.

Source Summary by GovInfoNow · govinfonow.com/recall/46239-pfizer-us-pharmaceutical-group-recalls-advil-pm-caplets-ibuprofen-200 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1166-2014

Cite this page

“Advil PM Caplets Recall: Subpotent Diphenhydramine.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46239-pfizer-us-pharmaceutical-group-recalls-advil-pm-caplets-ibuprofen-200. Based on FDA recall #D-1166-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1166-2014%22&limit=1).

The FDA announced on Feb. 26, 2014, that Pfizer Us Pharmaceutical Group voluntarily recalled Advil PM Caplets due to subpotent drug risks. The recall affects 70,704 bottles distributed nationwide because of out-of-specification test results for Diphenhydramine citrate.

How to tell if you have it

  • Brand: Advil
  • Product: Advil PM Caplets (Ibuprofen, 200 mg / Diphenhydramine citrate, 38 mg)
  • Packaging: 120 count bottle
  • NDC: 0573-0164-43
  • Lot code: G85041
  • Quantity: 70,704 bottles

The hazard

The FDA stated the lot is being recalled because of out-of-specification test results for Diphenhydramine citrate. This constitutes a subpotent drug hazard.

Context

GovInfoNow's records show Pfizer Us Pharmaceutical Group has 3 other recalls on record since 2013-09-04. Other recent recalls of similar products include Bell Pharmaceuticals Carbamide Peroxide 6.5% Recall (2026-06-25), Major Pharmaceuticals Levothyroxine Tablets Recall (2026-07-13), and Bell Pharmaceuticals Clinere Carbamide Peroxide Recall (2026-06-25).

How to tell if you have this one

Check your bottle for NDC 0573-0164-43 and lot number G85041. The product is Advil PM Caplets (Ibuprofen, 200 mg / Diphenhydramine citrate, 38 mg) in a 120 count bottle.

  • Brand
    Advil
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your bottle

    Verify if your Advil PM Caplets have NDC 0573-0164-43 and lot number G85041.

  2. Contact Pfizer for remedy details

    The recall record does not specify a return or replacement process; contact the manufacturer for further instructions.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 16 months after the firm started it.

1. Firm started the recall: Feb 26, 201412. FDA classified it Class III: Mar 18, 201423. Published in FDA’s Enforcement Report: Mar 26, 201434. FDA terminated the recall: Jul 10, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1166-2014 (February 26, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1166-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA